Drug Shortage Report for SPRYCEL

Last updated on 2017-08-02 History
Report ID 16413
Drug Identification Number 02360810
Brand name SPRYCEL
Common or Proper name dasatinib
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) DASATINIB
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 BTL X 30
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-08-04
Actual start date
Estimated end date 2017-08-04
Actual end date 2017-08-03
Shortage status Avoided shortage
Updated date 2017-08-02
Company comments Product on allocation, other strengths are available.
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-08-02 French Compare
v5 2017-08-02 English Compare
v4 2017-07-29 French Compare
v3 2017-07-29 English Compare
v2 2017-07-19 French Compare
v1 2017-07-19 English Compare

Showing 1 to 6 of 6